Pharma’s AI prospects get nudged into the future with EU’s AI act
Experts predict growing pains as the life sciences sector moves to adapt to the EU AI Act.
Business & Regulation
EU Health Data Space strikes a chord in EU harmonisation plans
EU reshapes HTAs: is the industry ready for it?
Sanofi increases ownership stake partaking in pharma buyback trend
Flu vaccine strategy on the line as new US leaders anticipated to take charge
US Border Protection warns pharma of risks with incorrect biologic importation
WuXi debates sale of pharma operations as BIOSECURE Act advances
Chronic diseases “as urgent as climate change,” says Novo Nordisk CSO
